A Comparison of EGFR Mutation Testing Methods in Lung Carcinoma: Direct Sequencing, Real-time PCR and ImmunohistochemistryBárbara Angulo, Fernando López‐Ríos|PLoS ONE|2012Cited by 107
Updated guidelines for predictive biomarker testing in advanced non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical OncologyPilar Garrido, Fernando López‐Ríos|Clinical & Translational Oncology|2019Cited by 104
Assessment of a New ROS1 Immunohistochemistry Clone (SP384) for the Identification of ROS1 Rearrangements in Patients with Non–Small Cell Lung Carcinoma: the ROSING StudyEsther Conde, Fernando López‐Ríos|Journal of Thoracic Oncology|2019Cited by 71
Immune Checkpoint Inhibitors in Urothelial Carcinoma: Recommendations for Practical Approaches to PD-L1 and Other Potential Predictive Biomarker TestingAntonio López-Beltrán, Markus Eckstein, Rodolfo Montironi et al.|Cancers|2021Cited by 34